DrugDashboards

Market view

abatacept · Injection, Powder, Lyophilized, For Solution

3 marketed package NDCs · 3 active manufacturers

Most dispensed: 125 mg/mL · Injection, Solution · #4 syringe, glass/carton / 1 ml in 1 syringe, glass

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately. Historically, drugs in this position went on to a new shortage within 90 days about 0.4% of the time — roughly 3× the typical drug (0.1%).

What changed in the last 90 days

Every detected change for abatacept, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • OrenciaAug 19, 2026
    Price down
    NADAC $1470.39988 → $1470.23745 per unit (-0.01%)
  • OrenciaAug 19, 2026
    Price up
    NADAC $1467.36688 → $1468.73806 per unit (+0.09%)
  • OrenciaJul 22, 2026
    Price down
    NADAC $1468.82067 → $1467.36688 per unit (-0.1%)
  • OrenciaJul 22, 2026
    Price down
    NADAC $1470.77872 → $1470.39988 per unit (-0.03%)

Common questions

Is Abatacept in shortage right now?
No. FDA does not currently list Abatacept in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Abatacept?
3 companies have marketed Abatacept in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
What does Abatacept cost?
The typical pharmacy pays about $1,469.49 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.